Sofwave Medical Ltd (SOFW) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has a cash flow conversion efficiency ratio of -0.014x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-494.69K ≈ $-1.33K USD) by net assets (ILA35.33 Million ≈ $94.73K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sofwave Medical Ltd market capitalisation for the company's overall valuation and market capitalisation.
Sofwave Medical Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Sofwave Medical Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SOFW stock price and chart for real-time trading data and today's change.
Sofwave Medical Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sofwave Medical Ltd ranked by their cash flow conversion efficiency. Review Sofwave Medical Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Logo Yazilim Sanayi ve Ticaret AS
IS:LOGO
|
0.134x |
|
HannsTouch Solution Inc
TW:3049
|
-0.043x |
|
Bear Creek Mining Corporation
V:BCM
|
0.192x |
|
TTS (TRANSPORT TRADE SERVICES)
RO:TTS
|
0.033x |
|
KNEAT.COM INC.
F:FOBK
|
-0.047x |
|
Mia Teknoloji AS
IS:MIATK
|
0.025x |
|
SuperX AI Technology Limited
NASDAQ:SUPX
|
-0.176x |
|
Schweizerische Nationalbank
SW:SNBN
|
0.000x |
Annual Cash Flow Conversion Efficiency for Sofwave Medical Ltd (2019–2025)
The table below shows the annual cash flow conversion efficiency of Sofwave Medical Ltd from 2019 to 2025. Also see SOFW total asset value for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA32.72 Million ≈ $87.71K |
ILA15.08 Million ≈ $40.44K |
0.461x | +571.96% |
| 2024-12-31 | ILA24.53 Million ≈ $65.75K |
ILA-2.40 Million ≈ $-6.42K |
-0.098x | +59.19% |
| 2023-12-31 | ILA26.34 Million ≈ $70.62K |
ILA-6.31 Million ≈ $-16.91K |
-0.239x | +27.61% |
| 2022-12-31 | ILA32.34 Million ≈ $86.70K |
ILA-10.69 Million ≈ $-28.67K |
-0.331x | -636.46% |
| 2021-12-31 | ILA46.70 Million ≈ $125.21K |
ILA-2.10 Million ≈ $-5.62K |
-0.045x | +98.57% |
| 2020-12-31 | ILA1.53 Million ≈ $4.11K |
ILA-4.80 Million ≈ $-12.88K |
-3.133x | -336.15% |
| 2019-12-31 | ILA4.12 Million ≈ $11.03K |
ILA-2.96 Million ≈ $-7.92K |
-0.718x | -- |
About Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and … Read more